- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/76 - Albumins
Patent holdings for IPC class C07K 14/76
Total number of patents in this class: 419
10-year publication summary
|
22
|
43
|
34
|
33
|
45
|
28
|
23
|
30
|
28
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| EpiVax, Inc. | 72 |
16 |
| Neutrolis, Inc. | 33 |
12 |
| Bioverativ Therapeutics Inc. | 213 |
11 |
| Perfect Day, Inc. | 53 |
10 |
| Zymeworks Inc. | 260 |
8 |
| Sanofi Aatd Inc. | 17 |
8 |
| Medicenna Therapeutics Inc. | 42 |
6 |
| Sartorius Albumedix Limited | 47 |
6 |
| Centre National de La Recherche Scientifique | 10805 |
5 |
| Mayo Foundation for Medical Education and Research | 3336 |
5 |
| Ablynx N.V. | 410 |
5 |
| Hamlet Pharma AB | 18 |
5 |
| Keros Therapeutics, Inc. | 71 |
5 |
| Invitria, Inc. | 42 |
5 |
| Massachusetts Institute of Technology | 10172 |
4 |
| The Brigham and Women's Hospital, Inc. | 2244 |
4 |
| CSL Behring GmbH | 353 |
4 |
| Georgia State University Research Foundation, Inc. | 352 |
4 |
| Jubilant DraxImage Inc. | 151 |
4 |
| Regents of the University of Minnesota | 2764 |
4 |
| Other owners | 288 |